Concepedia

Maëlle Duffey

MD

13

Publications

460

Citations

11

H-Index

2016

Active since

Affiliations

Medicines for Malaria Venture(Current)

GlaxoSmithKline (Spain)

Columbia University Irving Medical Center

Massachusetts Institute of Technology

University of California San Diego

Maëlle Duffey is an author at Medicines for Malaria Venture specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2016–2024

13

Publications

13

Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration

Yun Dong, Roman Fischer, Petrus J.W. Naudé et al. · Proceedings of the National Academy of Sciences · 2016 · 166 citations · Full text

Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps

Maëlle Duffey, Ravindra P. Jumde, Renata M. A. da Costa et al. · ACS Infectious Diseases · 2024 · 54 citations · Full text

, , +19

Selective Activation of Tumor Necrosis Factor Receptor <scp>II</scp> Induces Antiinflammatory Responses and Alleviates Experimental Arthritis

Roman Fischer, Marcel Proske, Maëlle Duffey et al. · Arthritis & Rheumatology · 2018 · 42 citations

The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance

James M. Murithi, Ioanna Deni, Charisse Flerida A. Pasaje et al. · Cell chemical biology · 2021 · 27 citations · Full text

Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>

Martin A. Lowe, Á. de Pablo Cárdenas, Jean‐Pierre Valentin et al. · Journal of Medicinal Chemistry · 2022 · 27 citations · Full text

Rows per page

1–5 of 13